185 related articles for article (PubMed ID: 24333110)
41. Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer.
Djaladat H; Bruins HM; Miranda G; Cai J; Skinner EC; Daneshmand S
J Urol; 2012 Dec; 188(6):2134-8. PubMed ID: 23083874
[TBL] [Abstract][Full Text] [Related]
42. Upper urinary tract recurrence following radical cystectomy for bladder cancer.
Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
Int J Urol; 2007 Jun; 14(6):496-9. PubMed ID: 17593092
[TBL] [Abstract][Full Text] [Related]
43. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
[TBL] [Abstract][Full Text] [Related]
44. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
[TBL] [Abstract][Full Text] [Related]
45. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
46. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
[TBL] [Abstract][Full Text] [Related]
47. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Bolenz C; Gilfrich C; Otto W; Trojan L; Herrmann E; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Wieland WF; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
J Urol; 2012 Apr; 187(4):1210-4. PubMed ID: 22335861
[TBL] [Abstract][Full Text] [Related]
48. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.
Mitra AP; Quinn DI; Dorff TB; Skinner EC; Schuckman AK; Miranda G; Gill IS; Daneshmand S
BJU Int; 2012 Mar; 109(6):846-54. PubMed ID: 21812902
[TBL] [Abstract][Full Text] [Related]
49. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
[TBL] [Abstract][Full Text] [Related]
50. The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy.
Bhindi B; Yu J; Kuk C; Sridhar SS; Hamilton RJ; Finelli A; Jewett MA; Evans A; Fleshner NE; Zlotta AR; Kulkarni GS
J Urol; 2014 Sep; 192(3):714-9. PubMed ID: 24594406
[TBL] [Abstract][Full Text] [Related]
51. Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
Soria F; Moschini M; Wirth GJ; Gust KM; Klatte T; Briganti A; Gontero P; Abufaraj M; Özsoy M; Karakiewicz PI; Shariat SF
Urology; 2017 Aug; 106():119-124. PubMed ID: 28506860
[TBL] [Abstract][Full Text] [Related]
52. Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes.
Yoo SH; Kim H; Kwak C; Kim HH; Jung JH; Ku JH
Urol Int; 2019; 103(3):291-296. PubMed ID: 31461728
[TBL] [Abstract][Full Text] [Related]
53. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
54. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
[TBL] [Abstract][Full Text] [Related]
55. Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer.
Luchey AM; Lin HY; Yue B; Agarwal G; Gilbert SM; Lockhart J; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
J Urol; 2015 Nov; 194(5):1220-5. PubMed ID: 26055823
[TBL] [Abstract][Full Text] [Related]
56. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301
[TBL] [Abstract][Full Text] [Related]
57. Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
Hussein AA; Elsayed AS; Aldhaam NA; Jing Z; Osei J; Kaouk J; Redorta JP; Menon M; Peabody J; Dasgupta P; Khan MS; Mottrie A; Stöckle M; Hemal A; Richstone L; Hosseini A; Wiklund P; Schanne F; Kim E; Ho Rha K; Guru KA
J Urol; 2019 Nov; 202(5):927-935. PubMed ID: 31188729
[TBL] [Abstract][Full Text] [Related]
58. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
[TBL] [Abstract][Full Text] [Related]
59. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
[TBL] [Abstract][Full Text] [Related]
60. The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy.
Large MC; Cohn JA; Kiriluk KJ; Dangle P; Richards KA; Smith ND; Steinberg GD
J Urol; 2013 Sep; 190(3):923-7. PubMed ID: 23454159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
